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1. Introduction  
Since it was first recognized in early 1980s, the Acquired Immunodeficiency Syndrome 
(AIDS) has been one of the most destructive diseases recorded in the world history.  The 
devastating impact of HIV/AIDS on individual patient, family, community and the nation 
is vast. The disease not only robs a country of its monetary resources in covering for the 
costs of HIV prevention and treatment, but also of the nation’s human resources when 
young productive lives are affected. The latest statistics suggested that the overall growth of 
the disease has stabilised with declining number of new HIV cases since the last decade. 
However, the number of people living with HIV/AIDS (PLWHA) remained high and 
appeared to be still on the rise (UNAIDS, 2010).  
With increasing availability and use of highly active antiretroviral therapy (HAART) in 
1996, fewer deaths due to AIDS-related diseases have been observed. Worldwide, about 1.8 
million HIV-related deaths were reported in 2009 as compared to the peak 2.1 million in 
2004. In Southern Alberta, Canada, analysis of AIDS death records between pre-HAART 
(1984-1996) and HAART (1997-2003) periods revealed reduction in crude mortality rate from 
117 deaths per 1000 patient-years pre-HAART to 24 in the HAART period (Krentz et al., 
2005). Across Europe, the HIV-related death rates reduced substantially between September, 
1995, and March, 1998, in a large cohort of 4270 HIV-infected patients to less than a fifth of 
their previous level (Mocroft et al., 1998). A study in Taiwan compared the mortality rate of 
10,162 HIV-infected patients whose diagnosis was made in three different periods: the pre-
HAART period, from 1 January 1984 to 31 March 1997; the early HAART period, from 1 
April 1997 to 31 December 2001; and the late HAART period, from 1 January 2002 to 31 
December 2005 (Yang et al., 2008). Results showed that the mortality rate of HIV-infected 
patients declined significantly from 10.2 deaths per 100 person-years in the pre-HAART 
period to 6.5 deaths and 3.7 deaths per 100 person-years in the early and late HAART 
periods, respectively. This increase in survival rates contributes to the increasing number of 
PLWHA as AIDS is no longer a lethal disease but has been transformed into a chronic 
condition. 
Oral lesions are common in PLWHA. Some oral manifestations have been documented as 
early markers of HIV infection and as predictors of disease progression. Among the most 
common oral manifestations of HIV include oral candidiasis, oral hairy leukoplakia and 
necrotizing ulcerative periodontitis (Coogan et al., 2005; Ranganathan & Hemalatha, 2006). 
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Oral problems may give rise to physical, functional and emotional discomfort, dysfunction, 
or disability which in turn has been shown to affect the overall quality of life (QOL) of 
PLWHA (Coulter et al., 2002; Yengopal & Naidoo, 2008). As people are living longer with 
HIV, the study on QOL has emerged as an important factor in management of HIV infection 
(Grossman et al., 2003). This chapter aims to describe the epidemiology and manifestations 
of oral lesions commonly associated with  HIV/AIDS and the impact of oral health 
problems on the QOL of PLWHA.    
2. Epidemiology of HIV-associated oral manifestations 
Oral lesions are common in individuals with HIV infection. Many epidemiologic studies 
have been conducted around the world to study the prevalence of oral lesions among 
PLWHA not long after the virus was first discovered and reported in the United States in 
1981. Bhayat et al. (2010) reported that oral manifestations of HIV/AIDS occurred in more 
than 60% of HIV-positive patients and were often the first sign of underlying 
immunosuppression. Another study by Nittayananta et al. (2002) found that more than 90% 
of HIV-infected individuals will have at least one oral manifestation during the illness. Not 
only HIV-related oral lesions are among the early clinical features of the infection, but can 
also indicate the stage and progress of the disease. Prevalence of oral lesions has been 
shown to be significantly higher in individuals with a CD4+ count less than 200 cells/mm3 
and a viral load greater than 3000 copies/mL (Bravo et al., 2006; Greenspan et al., 2000; 
Tappuni & Fleming, 2001). The importance of oral lesions as clinical indicators of HIV 
infections and markers of clinical progression to AIDS has been demonstrated in many 
studies that reported their association with CD4+ depletion and high viral load (Bravo et al., 
2006; Campo et al., 2002; Chattopadhyay et al., 2005; Glick et al., 1994; Greenspan et al., 2000; 
Patton, 2000; Ramírez-Amador et al., 2003; Shiboski et al., 2001). 
A comprehensive review of epidemiologic studies on HIV-related oral lesions reported from 
developed and developing countries over more than a decade, encompassing the pre-
HAART and early-HAART period from 1986 to 2000, revealed oral candidiasis as the most 
common lesion found in all ages across the world (Patton et al., 2002). Prevalence of the 
lesion, however, ranged considerably from as low as 5% found in two separate studies in 
Minnesota (Little et al., 1994; Melnick et al., 1991) to as high as 94% among those with AIDS-
defining illnesses in Zaire (Tukutuku et al., 1990). This review paper by Patton et al. (2002), 
which was the outcome of an International Workshop that addressed the prevalence and 
classification of HIV/AIDS associated oral lesions, identified hairy leukoplakia as the 
second most reported oral lesion with prevalence that ranged from 2% in Nairobi, Kenya 
(Wanzala et al., 1989) to 43% in Mexico (Gillespie & Mariño, 1993). This wide-ranged 
prevalence was due to variations in the populations studied, including differences in the 
prevalence of AIDS diagnoses, CD4+ count, or diagnostic techniques used. 
Prevalence of other oral lesions commonly associated with HIV also varies according to 
region of the world and the population examined (Patton et al., 2002). According to the 
review by Patton et al. (2002), Kaposi’s sarcoma was reported to be present in 12% of 83 
heterosexual AIDS patients in Kinshasa, Zaire (Tukutuku et al., 1990), while higher 
frequency of 38% was found among 84 AIDS patients in the United States (Roberts et al., 
1988). HIV-related periodontal lesions, namely linear gingival erythema, necrotizing 
ulcerative gingivitis and necrotizing ulcerative periodontitis were found in up to 22% of 
patients in New York (Lamster et al., 1994), 24% in Argentina (Gillespie & Mariño, 1993), 
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and 23% in India (Anil & Challacombe, 1997), respectively. Of these periodontal lesions, 
necrotizing ulcerative periodontitis is the most severe form. Lower prevalence was reported 
for non-Hodgkin’s lymphoma which was detected in 5% of 124 AIDS patients in Thailand 
(Nittayananta & Chungpanich, 1997) and 2% in San Francisco (Silverman Jr et al., 1986). 
The introduction of HAART has not only resulted in significant decline in mortality 
associated with HIV across the world, significant reduction was also seen in the prevalence 
of most AIDS-defining illnesses and opportunistic infections (Buchacz et al., 2010; Kaplan et 
al., 2000; Mocroft et al., 2004). Similarly, there has been a downward trend in the prevalence 
of oral opportunistic lesions in response to the use of HAART (Franceschi et al., 2008; Patton 
et al., 2000; Ramírez-Amador et al., 2003; Shiboski, 2002; Yang et al., 2010). Notable 
reduction was reported in the prevalence of two most common HIV-associated lesions, oral 
candidiasis and hairy leukoplakia (Eyeson et al., 2002; Nicolatou-Galitis et al., 2004; Patton 
et al., 2000; Ramírez-Amador et al., 2003). Despite the great success of HAART, the therapy 
remains an expensive option that may be unaffordable to many, especially those living in 
low-income countries (WHO et al., 2009). It was reported that at least 5 million PLWHA in 
need of treatment are not able to have access to the life-prolonging therapy although the 
availability of HAART has increased rapidly from 7% in 2003 to 42% in 2008 to reach over 
four million people in low- and middle-income countries.  
Nevertheless, even when HAART is available to reduce the viral load, many other factors 
have been suggested to predispose to oral lesions in HIV-infected individuals such as 
cigarette smoking, heroin/methadone use, poor oral hygiene, and socio-demographic 
factors such as older age, lower education level and lower household income 
(Chattopadhyay et al., 2005; Ferreira et al., 2007; Greenspan et al., 2000; Nittayananta et al., 
2001; Noce et al., 2009; Shiboski et al., 1999a). In addition, studies have suggested that HIV 
disease progression can be influenced by psychological factors (Leserman, 2003; Leserman, 
2008). Specifically, feelings of hopelessness, depressed mood, and avoidant coping have 
been shown to be associated with reduced CD4+ cell count and increased viral load in a 
study among 177 HIV-positive patients (Ironson et al., 2005). Owing to the established 
association of CD4+ count and viral load with prevalence of oral lesions, it is possible that 
psychosocial factors may also have an effect on the incidence of oral lesions in HIV patients.  
Besides, related psychological and social impact including stigma of HIV infection should 
also be considered in general management of PLWHA as these may further influence 
health-seeking behaviour, diagnosis, quality of care provided, treatment and its outcomes, 
and adherence to therapy (Carr & Gramling, 2004; WHO, 2008). There have been several 
reports that suggested while the oral health needs among HIV-infected patients are high, 
utilization of care unfortunately has been poor (Dobalian et al., 2003; Mascarenhas & Smith, 
1999; Patton et al., 2003; Shiboski et al., 1999b). These circumstances can develop a vicious 
cycle as poor use of services will undoubtedly create greater unmet needs which in turn 
further deteriorate oral conditions and increase the oral health impact among PLWHA. On 
the whole, although the prevalence of oral health conditions among PLWHA has mainly 
reduced, the problem remains as a fundamental component of disease progression. It is 
important that clinicians are able to diagnose oral lesions related to the infection, recognise 
the predisposing and risk factors, and initiate appropriate therapy. 
3. Oral manifestations strongly associated with HIV 
In 1993, the EC-Clearinghouse on Oral Problems Related to HIV Infection and the World 
Health Organization (WHO) Collaborating Centre on Oral Manifestations of the 
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Immunodeficiency Virus (EC-Clearinghouse & WHO, 1993) published a consensus on the 
classification of oral manifestations related with HIV infection and their diagnostic criteria. 
The lesions were grouped into three categories depending on their strength of association 
with the infection. Oral candidiasis, hairy leukoplakia, specific forms of periodontal disease 
(linear gingival erythema, necrotizing ulcerative gingivitis and necrotizing ulcerative 
periodontitis), Kaposi's sarcoma and non-Hodgkin's lymphoma have been classified as oral 
lesions strongly associated with HIV infection. 
3.1 Oral candidiasis  
Oral candidiasis is predominantly caused by Candida albicans (Laskaris, 2000). It is an early 
manifestation of HIV that can occur in patients who appear otherwise healthy.  In HIV-
infected patients, candidal infection can occur in two major forms, pseudomembranous and 
erythematous. The pseudomembranous type presents as white or yellowish spots or plaque 
that can be wiped off, revealing an erythematous surface. The soft palate, buccal mucosa, 
lateral borders of the tongue, commisures, lips and gingival are more frequently affected 
(Laskaris, 2000). On the other hand, the erythematous form presents as red area usually on 
the palate and the dorsum of the tongue although occasionally it can be located on the 
buccal mucosa (EC-Clearinghouse & WHO, 1993; Laskaris, 2000). White spots and plaque 
may be seen, but these are not usually conspicuous (Laskaris, 2000).  
Clinical diagnosis of oral candidiasis is confirmed with the presence of candidal hypae in 
oral smears of the affected oral mucosa (Ramírez-Amador et al., 2006). The treatment of oral 
candidiasis includes azole (ketoconazole, fluconazole, itraconazole) and polyene drugs 
(nystatin and amphotericine B). However, resistance to these drugs and recurrences are 
frequent (Laskaris, 2000). 
3.2 Oral hairy leukoplakia  
Oral hairy leukoplakia is commonly found in patients at the late stage of HIV infection 
(Greenspan & Greenspan, 1992). It usually appears when CD4+ T cell count drops below 150 
cells/mm3 (Glick et al., 1994). Although the actual cause and pathogenesis of the lesion is 
unclear, Epstein-Barr virus seems to play an important role (Cruchley et al., 1997; Tüzün et 
al., 2005). It is usually diagnosed clinically as asymptomatic, non-removable, flat or 
vertically correlated bilateral whitish or gray lesions on the lateral margins of the tongue 
(EC-Clearinghouse & WHO, 1993; Laskaris, 2000). Sometimes it occurs on the dorsum of the 
tongue and occasionally on the buccal mucosa. Appearance of the lesion may vary from 
subtle translucent white to dense white plaque, and Epstein-Barr virus has been detected by 
in situ hybridization of the lesion (Webster-Cyriaque et al., 1997). Oral hairy leukoplakia is 
almost always asymptomatic, self-limiting and often requires no treatment. Antifungal 
therapy may resolve the symptoms of superimposed candidosis but the lesion will not 
resolve completely. High dose acyclovir, zidovudine and podophyllin are the drugs of 
choice while surgical excision can be offered to patients who request for removal of the 
lesion (Scully & McCarthy, 1992). Oral hairy leukoplakia tends to recur when treatment is 
discontinued (Laskaris, 2000). 
3.3 Linear gingival eythema  
Linear gingival erythema appears as distinct fiery red band about 2-3 mm width along the 
free gingival margin (EC-Clearinghouse & WHO, 1993). Initially, the lesion was thought to 
be directly associated with HIV, and was thus previously called HIV-associated gingivitis. 
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However, subsequent evidence showed that the lesion is not specific to HIV infection. It also 
occurs in HIV negative immunocompromised patients and was renamed as linear gingival 
erythema. Clinical oral examination will reveal inflamed gingival tissues which bleed easily 
upon manipulation. There is absence of ulceration, periodontal pocket, or attachment loss.  
Unlike conventional periodontal disease, linear gingival erythema is not associated with the 
amount of plaque. It does not respond well to oral hygiene measures, removal of dental 
plaque and calculus. However, plaque and calculus should be removed in these patients to 
help reduce the erythema and possibly accelerate the healing. This procedure should be done 
very carefully to avoid excessive bleeding. Therapeutic protocol for linear gingival erythema 
includes 0.12% chlorexidine gluconate mouth rinse twice daily and systemic antibiotics such as 
metronidazole (Flagyl) if the lesion persists despite the preceding therapy. 
3.4 Necrotizing ulcerative gingivitis  
Clinically, necrotizing ulcerative gingivitis may present with fiery red and swollen gingiva 
as well as destruction of one or more interdental papillae. The onset of the disease is either 
acute or subacute. In acute stage, ulceration, necrosis and sloughing of both gingival margin 
and the top of interdental papillae are common findings.  The anterior gingiva is most 
frequently affected. Pain, bleeding and halitosis are the common symptoms. Subacute stage 
is characterized by localized or generalized acute, painful ulceronecrotic lesions of the oral 
mucosa beyond the gingiva. In acute phase, treatment includes metronidazole, 500mg three 
times daily for 6 to 8 days and topical mouthwashes. Conventional periodontal treatment 
(plaque control measures, root planing, scaling) should follow (Laskaris, 2000). 
3.5 Necrotizing ulcerative periodontitis  
HIV-associated  periodontitis is a serious and rapidly progressive condition, usually occur 
in severe immunosuppression when CD4+ T cell count is less than 100 cells/mm3 (Glick et 
al., 1994). Clinically, necrotizing ulcerative periodontitis is characterized by gingival 
ulceration and necrosis as well as rapid and progressive destruction of the periodontal 
attachment and loosening of teeth (EC-Clearinghouse & WHO, 1993; Patton, 2003). 
Spontaneous bleeding, deep-seated pain, halitosis, erythema and edema are the prominent 
features (Laskaris, 2000). This condition can be treated with systemic administration of 
metronidazole or tetracycline for 8 to 12 days in conjunction with topical antibacterial 
mouthwashes. Conventional periodontal treatment maintenance and prevention should 
follow (Robinson, 1997). However, relapses are common. 
3.6 Kaposi’s sarcoma  
Kaposi’s sarcoma is the most common malignancies in HIV-infected patients (Wood & 
Harrington Jr, 2005). Human Herpes Virus-8 has been found to be necessary but not 
sufficient for its development because other factors such as immunosuppression are also 
required (Boshoff et al., 1995; Laskaris, 2000; Whitby et al., 1995; Wood & Harrington Jr, 
2005). Clinically, in the early phase, patients with oral Kaposi’s sarcoma may present with a 
blue, red or purple macules on the palate, gingival and/or tongue (Casiglia & Woo, 2000; 
Glick et al., 1994). The lesion may progress to become raised and nodular, and subsequently 
may result in ulceration, bleeding and pain (Casiglia & Woo, 2000; Laskaris, 1996). Biopsy of 
the lesion is required to confirm the diagnosis (Laskaris, 2000). Histopathologically, it is 
characterized by proliferation of spindle-shaped cells that form the vascular channels 
(Casiglia & Woo, 2000; Wang et al., 2007). The differential diagnoses of oral Kaposi’s 
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sarcoma include bacillary angiomatosis, pyogenic granuloma, peripheral giant cell 
granuloma, leiomyoma, angiosarcoma, nevi, malignant melanoma and oral lesions of 
amyloidosis (Laskaris, 2000). 
Treatment for Kaposi’s sarcoma mainly focus on palliation and local control since 
chemotherapy may further suppress the immune system and favor the proliferation of the 
lesion (Gascón & Schwartz, 2000). Local measures include excision, laser ablation, radiation 
or intralesional injection. A small lesion may be completely excised or ablated.  
Radiotherapy reduces the pain and results in regression of the lesion. However, it may give 
rise to potential side effects such as taste loss, mucositis as well as superimposed candidal 
infection.  Prophylactic antifungal therapy with amphotericin B rinses and ketoconazole is 
beneficial to minimize this complication (Piedbois et al., 1994). Systemic involvement of 
Kaposi’s sarcoma is usually treated with chemotherapy. Regimens include the use of 
vinblastine as a single agent or combination of adriamycin, bleomycin and vincristine 
(Casiglia & Woo, 2000). 
3.7 Non-Hodgkin’s lymphoma  
Non-Hodgkin’s lymphoma is the second most common intraoral neoplasm in patients with 
HIV infection, particularly those with CD4+ count less than 100 cells/mm3 (Laskaris, 2000). 
As compared with healthy individuals, HIV patients have 60 to 70 times greater risk of 
developing the malignancy (Reynolds et al., 1993). Epstein Barr virus is a known risk factor 
for HIV-related non-Hodgkin’s lymphoma (Wood & Harrington Jr, 2005). Factors such as 
viral infection can precipitate either chronic antigenic stimulation or immunosuppression 
which may provide a preferential environment for the development of non-Hodgkin’s 
lymphoma (Fisher & Fisher, 2004).  
Clinically, patients may present with intraoral ulcerations or soft tissue masses which are 
painful and rapidly enlarged. The most common sites include palate, retromolar pad, 
tonsillar pillars and tongue (Green & Eversole, 1989). However, most HIV patients 
presented with oral non-Hodgkin’s lymphoma may already have nodal and extranodal 
involvement at the time of diagnosis (Carbone et al., 1995).  Patients with localized disease 
are treated with radiotherapy. Chemotherapy is another treatment option. However, 
chemotherapy can induce profound neutropenia which can be treated effectively with 
concomitant administration of granulocyte-macrophage colony–stimulating factor (Kaplan 
et al., 1991). Complete remission occurs in approximately 65% of patients with the median 
survival time between 4 and 11 months (Carbone et al., 1995).  Low CD4+ count and 
involvement of bone and extranodal site indicate poor prognosis (Levine et al., 1991). 
4. Oral health-related quality of life among PLWHA  
The effects of HIV infection on the QOL of those who live with it are substantial and have 
been well documented. While the symptoms of HIV vary according to the stage of infection, 
studies have shown that health-related QOL (HRQOL) of PLWHA declines as the disease 
progresses and as the number of symptoms increase (Hays et al., 2000; Lorenz et al., 2006; 
Lorenz et al., 2001). In view of the fact that oral manifestations are among the most common 
symptoms of HIV which may provide strong indication of the disease progress (Bravo et al., 
2006; Greenspan et al., 2000; Lewis et al., 2003 ; Patton, 2000; Pedreira et al., 2008), the 
presence of oral lesions can therefore have significant impact on the general well-being of 
individuals affected (Lorenz et al., 2001). 
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Coulter et al. (2002) conducted a longitudinal study to determine the association between 
self-perceived oral health and general health in a sample of adults receiving medical care for 
HIV in the United States. Data was obtained via personal interviews that were conducted in 
three phases on a cohort that initially consisted of 2,864 patients. Oral health was assessed 
using seven items with a five-point scale on oral-related pain and discomfort, worry, 
appearance, and function, which were adapted from the General Oral Health Assessment 
Index (GOHAI) developed originally to measure oral health problems of older adults 
(Atchison & Dolan, 1990), while the general health was assessed using 28 items on a 0 to 100 
scale that measure physical functioning and emotional well-being of the patients. In both 
measures, higher score indicated better health. Results of the study suggested that oral 
health was strongly associated with physical and mental health of individuals with HIV. 
The authors concluded that oral health is indeed an essential component of general health 
and thus should be included in the assessment of HRQOL among PLWHA. 
To date, available evidence on the association between oral symptoms and HRQOL among 
PLWHA is scarce. The impact of oral conditions in PLWHA was first reported by Coates et 
al. (1996) in a study among 54 HIV positive dental patients. The oral health status of patients 
with HIV, as measured by the Decayed, Missing, and Filled Teeth (DMFT) Index for 
measuring dental caries and the Community Periodontal Index of Treatment Needs 
(CPITN) for measuring periodontal disease, was  compared with general dental patients 
receiving public-funded care in Adelaide, South Australia, while the impact on HRQOL was 
evaluated against another sample of Adelaide residents. The results showed that the CPITN 
scores were higher among the HIV group compared with the control group although dental 
caries experience did not differ significantly. More importantly, HIV patients have reported 
greater impact on HRQOL aspects due to disabling oral conditions than the comparison 
group. The impact of oral conditions was measured using the Oral Health Impact Profile 
(OHIP) questionnaire (Slade & Spencer, 1994). 
The OHIP questionnaire has been used to measure the impact of oral diseases on life 
experiences in various groups of patients and individuals. Originally developed in English, 
the OHIP questionnaire has been translated into other languages including Japanese, 
Korean, Malay, and Chinese (Bae et al., 2007; Ide et al., 2006; Saub et al., 2007; Wong et al., 
2002). The questionnaire measures individual perceptions of impact, with questions divided 
into seven domains, namely functional limitation, physical pain, psychological discomfort, 
physical disability, psychological disability, social disability, and handicap. The original 
version contains 49 items (OHIP-49) as shown in Table 1.  
The OHIP questionnaire has been the most commonly used instrument for assessing the oral 
health-related QOL (OHRQOL) among PLWHA. A five-point Likert scale response format is 
used to assess the frequency of impact caused by oral conditions during the previous 12 
months, ranging from ‘never’ to ‘very often’. From the results, the prevalence of impact can 
be determined which is the percentage of respondents reporting 1 or more impacts ‘fairly 
often’ or ‘very often’ (Slade et al., 2005). This information enables identification of those 
whose oral health impacts are chronic rather than transitory. A shorter version of the OHIP 
questionnaire with 14 items (OHIP-14) is also available to be used in settings where the use 
of 49 items is  not suitable (Slade, 1997).  
Yengopal & Naidoo (2008)  used the OHIP questionnaire to assess the impact of oral lesions 
in a convenient sample of 150 HIV infected adults seen  at HIV clinics in Cape Town, South 
Africa. Two groups of HIV-positive patients were compared, a case group of 71 patients 
with HIV-associated oral manifestations, and a control group of 79 patients who had no  
www.intechopen.com
 
HIV-Infection – Impact, Awareness and Social Implications of Living with HIV/AIDS 
 
124 
Functional Limitation
 
 Had difficulty chewing any foods  
 Trouble pronouncing words  
 Noticed a tooth which doesn’t look 
right  
 Felt that appearance has been affected  
 Felt that breath has been stale  
 Felt that sense of taste has worsened  
 Had food catching in teeth or dentures  
 Felt that digestion has worsened  
 Felt that dentures have not been fitting 
properly 
Physical Pain 
 
 Had painful aching in mouth  
 Had a sore jaw  
 Had headaches  
 Had sensitive teeth with hot or cold 
food or drinks  
 Had toothache  
 Had painful gums  
 Found it uncomfortable to eat any 
foods  
 Had sore spots in mouth  
 Had uncomfortable dentures 
Psychological discomfort 
 
 Been worried by dental problems  
 Been self-conscious  
 Been miserable  
 Felt uncomfortable about appearance  
 Felt tense 
Physical Disability
 
 Speech has been unclear  
 People misunderstood some words  
 Felt there has been less flavour in food  
 Been unable to brush teeth properly  
 Had to avoid eating some foods  
 Had an unsatisfactory diet  
 Been unable to eat with dentures  
 Avoided smiling  
 Had to interrupt meals 
Psychological Disability 
 
 Sleep has been interrupted  
 Been upset  
 Found it difficult to relax  
 Felt depressed  
 Concentration has been affected  
 Been embarrassed 
Social Disability 
 
 Avoided going out  
 Been less tolerant of spouse or partner  
 Had trouble getting on with other 
people  
 Been a bit irritable with other people  
 Had difficulty doing usual job 
Handicap 
 
 Felt that general health has worsened  
 Suffered any financial loss  
 Been unable to enjoy other people’s 
company  
 Felt that life in general was less 
satisfying  
 Been totally unable to function  
 Been unable to work to full capacity  
Table 1. Dimensions and items of the full version of the OHIP questionnaire (OHIP-49). 
associated oral lesions. Results of the study revealed that oral candidiasis, angular cheilitis, 
and hairy leukoplakia were the most common oral lesions found among the cases, who also 
had significantly higher prevalence of other oral problems such as dental caries, 
periodontitis, dry mouth, and taste problems compared with patients in the control group. 
Data for assessment of impact obtained using the full version of the OHIP questionnaire was 
analysed by simple frequency count and by the use of item weights for each question. In 
general, the frequency count analysis showed that patients with HIV-associated oral lesions 
had higher impact scores in all oral health domains measured than those in the group 
without associated lesion. Further investigations using item weights showed that patients 
with associated oral lesions appeared to be more affected in terms of their functional 
limitation, physical pain, psychological discomfort, physical disability, and psychological 
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disability compared with the other two dimensions, social disability and handicap. In total, 
the impact scores remain significantly different between the two groups with the case group 
reporting higher impact than the control group. 
Similar results were found in a study by Mulligan et al. (2008) that compared a group of 
HIV-infected women (n = 597) with another group of at-risk HIV-negative women (n = 92). 
All the participants were part of the Women’s Interagency HIV Study (WIHS) cohort that 
investigated manifestations of HIV in women at six sites throughout the United States 
(Chicago, Los Angeles, Bronx, Brooklyn, San Francisco and Washington). However, for the 
OHRQOL study, the participants were selected among women from only four WIHS sites 
(excluding Brooklyn and Washington). The shorter version of OHIP questionnaire was used 
in this study. The OHRQOL were determined at the beginning, during, and end of the 
study. Results showed that HIV-infected women had higher OHIP-14 scores,  both at the 
baseline and during the study, than women at-risk. The difference between the two groups 
however was not significant at the last measurement. All things considered, the WIHS oral 
cohort study concluded that HIV-positive women had significantly poorer OHRQOL than 
HIV-negative women with an average of 10% difference in impact scores measured 
repeatedly over 5.5 years between the two groups. In addition, the HIV-positive group 
showed poorer oral health status than the control group as indicated by some dental caries 
and periodontal parameters measured clinically at the baseline. 
Oral health status of HIV-infected patients was also found to be poor in a study among a 
sample of 101 HIV-positive adult patients, 32 women and 69 men, seen at the 
Immunodeficiency Unit of the Cascais Hospital Center, Portugal (Santo et al., 2010). Clinical 
examinations of dental caries status, periodontal health, oral hygiene, and dental prosthesis 
status were done. The mean DMFT for the whole sample was 16.4 (SD 8.42), which was 
higher than that found among general adult populations reported in other studies. The 
mean DMFT of general adults was 11.4 (SD 7.87) in Istanbul, Turkey (Namal et al., 2008), 
12.5 (SD 7.1) in Oviedo, Spain (Alvarez-Arenal et al., 1996), and 12.8 in Australia (Do & 
Roberts-Thomson, 2007). For the age group of 35-44 years old, the mean DMFT was higher 
in the HIV infected Portuguese patients which was 15.8 (SD 8.32) compared with that found 
in general population of similar age group. In Athens, Greece, the mean DMFT was 14.6 (SD 
6.30) (Athanassouli et al., 1990), while in Pomerania, Germany, the mean DMFT was notably 
lower at 9.5 (SD 2.6) and 8.2 (SD 2.9) for female and male patients, respectively (Splieth et 
al., 2003). Further, examination of the periodontium showed that only 6.9% of the HIV-
positive patients presented with healthy periodontium, while the majority of them (77.2%) 
had periodontal pockets of at least 4-5mm depth. Oral hygiene was also poor among the 
majority of patients (63.4%) as determined by the Oral Hygiene Index that assessed the 
amount of plaque on six index teeth (Greene & Vermillion, 1960). With regard to dental 
prosthesis status and perceived needs, while 28.8% of the patients were wearing dental 
prosthesis,  51.4% claimed that they needed dentures in the maxilla and 49.5% in the 
mandible. The OHRQOL among the HIV-positive Portuguese patients was assessed using 
the OHIP-14 questionnaire. Common oral health impact reported by the patients include 
discomfort when eating any foods (58.4%), self-conscious because of teeth, mouth or 
dentures (45.5%), painful aching in mouth (38.6%), embarrassed because of oral problems 
(38.6%), and felt tense because of problems with teeth, mouth or dentures (34.7%). 
Of 33.3 million PLWHA around the world in year 2009, 2.5 million were children under 15 
years (UNAIDS, 2010), the prevalence and percentage of which has increased from 2.3 
million of 40.3 million PLWHA in year 2005 (UNAIDS, 2005). Similar to adults, oral 
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manifestations are common in children infected with HIV and have been found to be 
directly associated with the degree of immunosuppression and disease progression (Fonseca 
et al., 2000; Santos et al., 2001). In addition, oral candidiasis has also been the most 
commonly reported lesion in children, although the distributions of other oral lesions are 
somewhat different between children adults (Greenspan & Greenspan, 2002; Patton et al., 
2002; Ranganathan & Hemalatha, 2006). While there is a need to update and revise the 
classification of HIV-associated oral lesions in the paediatric population (Coogan et al., 
2005), the relevant documents seem to be inadequate. Studies on the oral health impact of 
children with HIV are also lacking although they suffer a higher prevalence of oral health 
problems like untreated dental caries than their peers (Flaitz et al., 2001; Massarente et al., 
2009; Pongsiriwet et al., 2003). 
A recent study on OHRQOL of 88 HIV-positive children in Brazil who had developed 
AIDS symptoms further highlighted the dismal picture (Massarente et al., 2011). 
Measurement of OHRQOL was done using the Brazilian Portuguese version of the Child 
Perceptions Questionnaire for children aged 11 to 14 years (CPQ 11-14) (Goursand et al., 
2008). The CPQ11-14 is a 37-item measure of OHRQOL encompassing four domains: oral 
symptoms, functional limitations, emotional and social well-being (Jokovic et al., 2006). 
It is designed specifically for children in the particular age group, taking into account 
their cognitive abilities and lifestyles. Besides, there is another version of the 
questionnaire, CPQ 8-10, developed for an age range from 8 to 10 years (Jokovic et al., 
2004). Results showed that higher viral load was associated with poorer OHRQOL where 
children with more severe AIDS manifestations ranked lower in all domains of OHRQOL 
measured. 
5. Summary 
Oral manifestations are common in PLWHA. Oral lesions, that may be seen as early clinical 
features of HIV infection, has been used to evaluate the immunological status of HIV-
infected patients as measured by reduced CD4+ T cell count and increased HIV RNA 
quantity in plasma. Besides being important indicators of HIV infection, oral lesions may 
predict progression of the disease to AIDS. Therefore it is imperative that health care 
providers, particularly oral health professionals, are able to identify the signs and symptoms 
of HIV-related oral lesions and recognize the significant role of these lesions in diagnosis 
and management of HIV infection. 
Introduction of HAART has resulted in considerable reduction in prevalence of oral lesions 
in HIV-infected individuals. However, as the HAART regimens may not be available or 
accessible to those in need, oral lesions thus remain as indispensable component of HIV 
infection. While there is continuing interest to investigate oral manifestations and 
immunologic responses among PLWHA, the study on OHRQOL has emerged as an 
important focus in HIV research. The social impact of HIV-related oral lesions and other oral 
health problems is recognised as an important attribute used to assess the outcomes of oral 
health services, to assist in cost-benefit analysis, and to monitor individual patient care. 
Although to date, studies on the OHRQOL among HIV-infected individuals are not many, 
the current available evidence suggested that the impact is substantial. Collectively, this 
chapter highlights the important role of dentists in the interdisciplinary management of 
PLWHA. 
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